Top Market Insights Stories
Market Insights
Sarepta's gene therapy gets FDA accelerated approval: Are fast-tracked drugs safe?
By Robert Langreth, Fiona Rutherford, Immanual John Milton and Madeline CampbellThe recommendation is a huge win for the pharmaceutical company, likely paving the way for the company's first-of-its-kind gene therapy for treat Duchenne muscular dystrophy, a deadly disease.










